Biotron Share Price and Company Fundamentals
Last traded: Today at 1:46 AM
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
-0.76
Market cap
$7.23M
Enterprise value
$3.05M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.biotron.com.au |
| Mailing address | 66 Hunter Street Level 2 Sydney NSW 2000 Australia |
| Phone / Fax | 61 2 9300 3344 / 61 2 9221 6333 |
Dividends
More: Biotron Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Biotron paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BIT dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Biotron.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D. | MD & Executive Director | ||
| Mr. Marcelo Mora ACIS, B.Bus Aasa | Company Secretary |
Profitability and management effectiveness
Profit margin
-17.57%
Operating margin
119329.96%
Return on assets
-28.73%
Return on equity
-206.96%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Biotron is 7.23M and its enterprise value is 3.05M. The enterprise value to revenue ratio of BIT is 1.68. The enterprise value to EBITDA ratio of BIT is -9.14.
Companies similar to Biotron (BIT)
Biotron (ASX:BIT) Frequently Asked Questions
1. What is Biotron's Stock Symbol?
Biotron trades on ASX under the ticker symbol "BIT".
2. What is Biotron's stock price today?
One share of BIT stock can currently be purchased for approximately $0.003.
3. How can I contact Biotron?
Biotron's mailing address is 66 Hunter Street Level 2 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9300 3344.
4. What is Biotron's official website?
The official website of Biotron is https://www.biotron.com.au.